Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the...
Jun 13, 2025, 10:46 AM EDT - 13 days ago
MMA
Mar 24, 2025, 10:51 PM EDT - 3 months ago
Feb 14, 2025, 4:00 PM EST - 4 months ago
Feb 7, 2025, 3:22 PM EST - 4 months ago
Nov 15, 2024, 8:00 AM EST - 7 months ago
PULM
Nov 14, 2024, 6:50 PM EST - 8 months ago
Nov 13, 2024, 7:00 AM EST - 8 months ago
Oct 8, 2024, 5:00 AM EDT - 9 months ago
OCS ONCO VRNA
Aug 23, 2024, 5:00 PM EDT - 10 months ago
Jul 31, 2024, 7:00 AM EDT - 11 months ago
Jun 27, 2024, 6:00 AM EDT - 1 year ago
May 22, 2024, 7:00 AM EDT - 1 year ago
May 20, 2024, 7:00 AM EDT - 1 year ago